Molecular Characterization of Aquaglyceroporine: A Novel Mutation in LmAQP1 from Leishmania major (MRHO/IR/75/ER)

Background: The first line treatment for cutaneous leishmaniasis is pentavalent antimony such as sodium stibogluconate (pentostam) and meglumine antimonite (glucantime). One of the most important ways to uptake the drug is by a transmembrane protein, called aquaglyceroporin encoded by Aquaglyceropr...

Full description

Bibliographic Details
Main Authors: Gilda ESLAMI, Maryam GHAVAMI, Ali Reza MORADI, Hamid NADRI, Salman AHMADIAN
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2019-09-01
Series:Iranian Journal of Parasitology
Subjects:
Online Access:https://ijpa.tums.ac.ir/index.php/ijpa/article/view/1757
id doaj-1ec462b16dbf45588ecda311e4825ded
record_format Article
spelling doaj-1ec462b16dbf45588ecda311e4825ded2021-04-02T11:05:09ZengTehran University of Medical SciencesIranian Journal of Parasitology1735-70202008-238X2019-09-0114310.18502/ijpa.v14i3.14871757Molecular Characterization of Aquaglyceroporine: A Novel Mutation in LmAQP1 from Leishmania major (MRHO/IR/75/ER)Gilda ESLAMI0Maryam GHAVAMI1Ali Reza MORADI2Hamid NADRI3Salman AHMADIAN4Research Center for Food Hygiene and Safety, Shahid Sadoughi University of Medical Sciences, Yazd, Iran AND Department of Parasitology and Mycology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, IranDepartment of Parasitology and Mycology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, IranDepartment of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, IranDepartment of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, IranResearch Center for Food Hygiene and Safety, Shahid Sadoughi University of Medical Sciences, Yazd, Iran AND Department of Parasitology and Mycology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran Background: The first line treatment for cutaneous leishmaniasis is pentavalent antimony such as sodium stibogluconate (pentostam) and meglumine antimonite (glucantime). One of the most important ways to uptake the drug is by a transmembrane protein, called aquaglyceroporin encoded by Aquaglyceroprotein1 (LmAQP1). In this study, molecular characterization of LmAQP1 was reported. Methods: Leishmania major (MRHO/IR/75/ER) promastigotes were cultured, and then DNA extraction and RNA extraction were done and followed by cDNA synthesis. Amplicons resulted from PCR and RT-PCR using specific primers were purified and sequenced. Molecular characterization was done by bioinformatically software such as BLST, ClustalW2, and RMSD. Results: Amplicons resulted from PCR and RT-PCR showed equal size in length. BLASTn analysis showed a point nucleotide change in LmAQP1 gene that encoded 282-amino-acid long protein with a mutation at position 154 including replacement of alanine by threonine. The observed mutation in the interested gene was assessed using the above-mentioned software. The mentioned gene was submitted at GenBank, NCBI with accession number of KU514052. Conclusion: The functional prediction of the protein encoded from LmAQP1 showed that the mentioned mutation could not affect the three-dimension structure, but it may modify the drug uptake potential of this important channel. Based on from LmAQP1 role, it seems to be an appropriate candidate for drug development. According to search through internet, this is the first report of LmAQP1 from L. major (MRHO/IR/75/ER). https://ijpa.tums.ac.ir/index.php/ijpa/article/view/1757Aquaporin 1LeishmaniaMolecular dynamics simulationAntimony
collection DOAJ
language English
format Article
sources DOAJ
author Gilda ESLAMI
Maryam GHAVAMI
Ali Reza MORADI
Hamid NADRI
Salman AHMADIAN
spellingShingle Gilda ESLAMI
Maryam GHAVAMI
Ali Reza MORADI
Hamid NADRI
Salman AHMADIAN
Molecular Characterization of Aquaglyceroporine: A Novel Mutation in LmAQP1 from Leishmania major (MRHO/IR/75/ER)
Iranian Journal of Parasitology
Aquaporin 1
Leishmania
Molecular dynamics simulation
Antimony
author_facet Gilda ESLAMI
Maryam GHAVAMI
Ali Reza MORADI
Hamid NADRI
Salman AHMADIAN
author_sort Gilda ESLAMI
title Molecular Characterization of Aquaglyceroporine: A Novel Mutation in LmAQP1 from Leishmania major (MRHO/IR/75/ER)
title_short Molecular Characterization of Aquaglyceroporine: A Novel Mutation in LmAQP1 from Leishmania major (MRHO/IR/75/ER)
title_full Molecular Characterization of Aquaglyceroporine: A Novel Mutation in LmAQP1 from Leishmania major (MRHO/IR/75/ER)
title_fullStr Molecular Characterization of Aquaglyceroporine: A Novel Mutation in LmAQP1 from Leishmania major (MRHO/IR/75/ER)
title_full_unstemmed Molecular Characterization of Aquaglyceroporine: A Novel Mutation in LmAQP1 from Leishmania major (MRHO/IR/75/ER)
title_sort molecular characterization of aquaglyceroporine: a novel mutation in lmaqp1 from leishmania major (mrho/ir/75/er)
publisher Tehran University of Medical Sciences
series Iranian Journal of Parasitology
issn 1735-7020
2008-238X
publishDate 2019-09-01
description Background: The first line treatment for cutaneous leishmaniasis is pentavalent antimony such as sodium stibogluconate (pentostam) and meglumine antimonite (glucantime). One of the most important ways to uptake the drug is by a transmembrane protein, called aquaglyceroporin encoded by Aquaglyceroprotein1 (LmAQP1). In this study, molecular characterization of LmAQP1 was reported. Methods: Leishmania major (MRHO/IR/75/ER) promastigotes were cultured, and then DNA extraction and RNA extraction were done and followed by cDNA synthesis. Amplicons resulted from PCR and RT-PCR using specific primers were purified and sequenced. Molecular characterization was done by bioinformatically software such as BLST, ClustalW2, and RMSD. Results: Amplicons resulted from PCR and RT-PCR showed equal size in length. BLASTn analysis showed a point nucleotide change in LmAQP1 gene that encoded 282-amino-acid long protein with a mutation at position 154 including replacement of alanine by threonine. The observed mutation in the interested gene was assessed using the above-mentioned software. The mentioned gene was submitted at GenBank, NCBI with accession number of KU514052. Conclusion: The functional prediction of the protein encoded from LmAQP1 showed that the mentioned mutation could not affect the three-dimension structure, but it may modify the drug uptake potential of this important channel. Based on from LmAQP1 role, it seems to be an appropriate candidate for drug development. According to search through internet, this is the first report of LmAQP1 from L. major (MRHO/IR/75/ER).
topic Aquaporin 1
Leishmania
Molecular dynamics simulation
Antimony
url https://ijpa.tums.ac.ir/index.php/ijpa/article/view/1757
work_keys_str_mv AT gildaeslami molecularcharacterizationofaquaglyceroporineanovelmutationinlmaqp1fromleishmaniamajormrhoir75er
AT maryamghavami molecularcharacterizationofaquaglyceroporineanovelmutationinlmaqp1fromleishmaniamajormrhoir75er
AT alirezamoradi molecularcharacterizationofaquaglyceroporineanovelmutationinlmaqp1fromleishmaniamajormrhoir75er
AT hamidnadri molecularcharacterizationofaquaglyceroporineanovelmutationinlmaqp1fromleishmaniamajormrhoir75er
AT salmanahmadian molecularcharacterizationofaquaglyceroporineanovelmutationinlmaqp1fromleishmaniamajormrhoir75er
_version_ 1724165639857242112